Global Medicare
360° Scientific Consulting
Our Services
Discover how we can help you
About Us
Global Medicare is a 360° scientific consultancy dedicated to turning cutting-edge research into real-world clinical solutions. Our multidisciplinary team—comprising physicians, PhD scientists, regulatory specialists, statisticians, and project managers—works in seamless collaboration to guide your project from concept through approval and beyond.
Unrivalled expertise across clinical, regulatory and quality domains
Proven methodologies for Advisory Boards, Clinical Trials & Medical Writing
End-to-end project management with transparent, data-driven workflows
Patient-centred approach that ensures high-quality care and outcomes
Our Advantages
Why Choose Global Medicare
At Global Medicare, we meld the rigour of a dynamic Advisory Board, the strength of our regulatory services and the efficiency of our clinical trial management with one clear aim: to accelerate the development and approval of your medical products, always ensuring the highest standards of quality and patient safety.
26+
Clinical trials managed
95 %
Target patient recruitment rate
Excellence at every trial stage.
End-to-End Clinical Trial Management
01
STRATEGY
Strategic Clinical Consultancy
02
DESIGN
Protocol Design & Planning
03
REGULATORY
Regulatory Services (EMA, FDA, AEMPS)
04
MONITORING
Monitoring & Pharmacovigilance
05
STATISTICS
Biostatistics & TMF Management
06
RECRUITMENT
Patient Recruitment & Reimbursement
Tailandia
Effect of Autologous Platelet Rich Plasma(a-PRP) Intrauterine Instillation in Infertile Women With Thin Endometrium in Frozen-thawed Embryo Transfer Cycle: a Randomized Controlled Study
Israel
Can Platelet-rich Plasma (PRP) Promote Endometrial Growth and Improve Pregnancy Outcome of Patients With Thin Endometrium Undergoing Assisted Reproductive Technology (ART) Treatments?
Irán
Study of the effect of platelet-rich plasma (PRP) and intralipid therapies on pregnancy outcomes in patients with recurrent implantation failure.
Egipto
Intrauterine Autologous PRP Infusion Compared to HRT for Enhancing Endometrial Thickness in Patients Undergoing ICSI.
EEUU
Platelet-rich plasma (PRP) for endometrial regeneration and repair: a prospective randomised pilot study.
China
Application of Platelet Rich Plasma (PRP) in Reproductive Medicine.
Grecia
Investigating the Efficiency of Autologous Platelet Rich Plasma Intraovarian Infusion on Improving Ovarian Functionality in Poor Ovarian Response Patients.
Venezuela
Efficacy of Autologous Exosomes vs Platelet-derived Growth Factors for Ovarian Regeneration in Women With Ovarian Insufficiency and Infertility: Observational, Prospective, Randomized, Comparative, Double-blind, Analytical, Prospective
Mongolia
Autologous Adipose Derived Mesenchymal Stromal Cell Transplantation in Patients With Idiopathic or Drug Induced Premature Ovarian Failure.
España
To evaluate the impact of an advanced therapy based on PRP (Platelet Rich Plasma) biologically enriched with exosomes.
Alemania
To evaluate the impact of an advanced therapy based on PRP (Platelet Rich Plasma) biologically enriched with exosomes.
Bulgaria
Effects of intrauterine administration of autologous peripheral blood mononuclear cells (PBMC) modulated with interferon Tau (IFNt) on endometrial cell populations.
EEUU
Bone Marrow Derived Stem Cells Mobilization for Treatment of Asherman's Syndrome, Atrophic Endometrium, and Recurrent Implantation Failure
Emiratos árabes
Fertility enhancement by ovarian and testicular regenerative treatment: (FERTILE): prospective observational study assessing safety and efficacy.
Platelet-rich plasma (PRP)
Exosomes
Stem cells
01.
International experience
In coordination of clinical trials.
02.
Multidisciplinary team
From experts in reproductive medicine, biotechnology and health.
03.
Focus on innovation
To offer the best therapeutic solutions.
MEET OUR TEAM
Experts in medicine, science, regulation and quality—all working together to drive your project forward.
Our strategic collaborators
Partner Testimonials
Prof. Dr. W. Küpker
Ärztlicher Direktor
M. Enciso
Scientific Director
Dr. med. Peter Fehr
Medical Director